Ropinirole Hcl
Rank #360 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$27.5M
Total Cost
1,204,903
Total Claims
$27.5M
Total Cost
38,496
Prescribers
$23
Cost per Claim
119,336
Beneficiaries
2,207,475
30-Day Fills
$713
Avg Cost/Provider
31
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$27.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $27.5M total
Top Prescribers of Ropinirole Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Scott Mcwilliams | Neurology | Rocky Point, NY | 147 | $43K |
| 2 | Stephanie Spain | Nurse Practitioner | Birmingham, AL | 123 | $37K |
| 3 | Antoine Mitri | Neurology | Downey, CA | 528 | $36K |
| 4 | Joseph Rudolph | Neurology | Willoughby Hills, OH | 167 | $32K |
| 5 | Paarth Shah | Neurology | Gilbert, AZ | 159 | $32K |
| 6 | Gulshan Oberoi | Neurology | Laurel, MS | 502 | $27K |
| 7 | Jill Marjama Lyons | Neurology | Albuquerque, NM | 71 | $26K |
| 8 | Lawrence Elmer | Neurology | Toledo, OH | 64 | $25K |
| 9 | Olga Waln | Neurology | Houston, TX | 53 | $23K |
| 10 | Lin Zhang | Neurology | Sacramento, CA | 152 | $22K |
| 11 | Benjamin Mccullough | Neurology | Birmingham, AL | 61 | $21K |
| 12 | Amy Colcher | Neurology | Camden, NJ | 59 | $20K |
| 13 | Erica Cabral | Nurse Practitioner | Dartmouth, MA | 94 | $20K |
| 14 | Julie Burnham | Neurology | Mount Clemens, MI | 64 | $19K |
| 15 | Andres Deik Acosta Madiedo | Neurology | Philadelphia, PA | 105 | $19K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 357 | Fostemsavir Tromethamine (Rukobia) | $27.8M | 3,094 |
| 358 | Colchicine (Colchicine) | $27.5M | 314,046 |
| 359 | Valsartan/Hydrochlorothiazide (Valsartan-Hydrochlorothiazide) | $27.5M | 510,583 |
| 360 | Ropinirole Hcl (Ropinirole Hcl) | $27.5M | 1,204,903 |
| 361 | Trifluridine/Tipiracil Hcl (Lonsurf) | $27.3M | 2,430 |
| 362 | Memantine Hcl/Donepezil Hcl (Namzaric) | $27.2M | 46,134 |
| 363 | Solifenacin Succinate (Solifenacin Succinate) | $27.1M | 343,174 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology